327 related articles for article (PubMed ID: 16301554)
1. Haemopoietic stem cell transplantation for genetic disorders.
Steward CG; Jarisch A
Arch Dis Child; 2005 Dec; 90(12):1259-63. PubMed ID: 16301554
[TBL] [Abstract][Full Text] [Related]
2. Stem cell transplantation for non-malignant disorders.
Steward CG
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):343-63. PubMed ID: 11030039
[TBL] [Abstract][Full Text] [Related]
3. Stem cell through present and future.
Sharma VK; Singh UK; Prasad R; Fletcher S
Indian J Pediatr; 2009 Jan; 76(1):51-6. PubMed ID: 19391003
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?
Hough R; Cooper N; Veys P
Br J Haematol; 2009 Dec; 147(5):593-613. PubMed ID: 19709086
[TBL] [Abstract][Full Text] [Related]
6. [Intrauterine transplantation of hematopoietic stem cells for therapy of genetic diseases].
Surbek DV; Hohlfeld P; Gratwohl A; Holzgreve W
Z Geburtshilfe Neonatol; 1997; 201(5):158-70. PubMed ID: 9440955
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell therapy for malignant diseases.
Shapira MY; Hai AA; Tsirigotis P; Resnick IB; Or R; Slavin S
Ann Med; 2007; 39(6):465-73. PubMed ID: 17852026
[TBL] [Abstract][Full Text] [Related]
8. Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
Gennery AR; Cant AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation for genetic disorders.
Soni S
J Ky Med Assoc; 2007 Jan; 105(1):12-6. PubMed ID: 17310873
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cells for the treatment of genetic disease.
Farah SB; Simpson TJ; Golbus MS
Clin Obstet Gynecol; 1986 Sep; 29(3):543-50. PubMed ID: 2875820
[No Abstract] [Full Text] [Related]
11. The sources and uses of hematopoietic stem cells keep increasing.
Trigg ME
Del Med J; 1998 Sep; 70(9):387-92. PubMed ID: 9805406
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease.
Shlomchik WD
Nat Rev Immunol; 2007 May; 7(5):340-52. PubMed ID: 17438575
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
Bone Marrow Transplant; 2006 Mar; 37(5):439-49. PubMed ID: 16444286
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG
Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953
[TBL] [Abstract][Full Text] [Related]
16. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
Satwani P; Cooper N; Rao K; Veys P; Amrolia P
Bone Marrow Transplant; 2008 Jan; 41(2):173-82. PubMed ID: 18037944
[TBL] [Abstract][Full Text] [Related]
17. Transplantation.
Curr Opin Oncol; 1997 Mar; 9(2):B41-7. PubMed ID: 9161802
[No Abstract] [Full Text] [Related]
18. Stem-cell transplantation for primary immunodeficiencies.
Bielorai B; Golan H; Rechavi G; Toren A
Isr Med Assoc J; 2002 Aug; 4(8):648-52. PubMed ID: 12183876
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood transplantation for non-malignant diseases.
Prasad VK; Kurtzberg J
Bone Marrow Transplant; 2009 Nov; 44(10):643-51. PubMed ID: 19802020
[TBL] [Abstract][Full Text] [Related]
20. Bone-marrow transplantation in non-malignant disease.
Wynn RF; Boelens JJ
Lancet; 2009 Sep; 374(9693):856-8. PubMed ID: 19729197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
